Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Sywak

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|December 2, 2009
The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytomaGoswin Y Meyer-Rochow, Geoff P Schembri, Diana E Benn, et al.
ANZ Journal of Surgery|November 27, 2013
Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronismJulian C Y Ip, Tony C Y Pang, Cindy K Pon, et al.
ANZ Journal of Surgery|July 2, 2009
Outcomes of minimally invasive surgery for phaeochromocytomaGoswin Y Meyer-Rochow, Patsy S H Soon, Leigh W Delbridge, et al.
Surgery|November 11, 2018
Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimeticsWillemijn Y van der Plas, Anton F Engelsman, Marille Umakanthan, et al.
World Journal of Surgery|October 24, 2013
Patterns of structural recurrence in papillary thyroid cancerSchelto Kruijff, Japke F Petersen, Paul Chen, et al.
Surgery|September 24, 2019
Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillanceJia F Lin, Pascal K C Jonker, Michelle Cunich, et al.
Surgery|December 8, 2010
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancerChristine J O'Neill, Martyn Bullock, Angela Chou, et al.
Surgery|January 3, 2014
Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinomaSchelto Kruijff, Ahmed M Aniss, Paul Chen, et al.
Cancers|August 8, 2020
Molecular Markers Guiding Thyroid Cancer ManagementCarolina Nylén, Robert Mechera, Isabella Maréchal-Ross, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines updateBenjamin J Worrall, Alexander Papachristos, Ahmad Aniss, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|December 2, 2009
The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytomaGoswin Y Meyer-Rochow, Geoff P Schembri, Diana E Benn, et al.
ANZ Journal of Surgery|November 27, 2013
Mutations in KCNJ5 determines presentation and likelihood of cure in primary hyperaldosteronismJulian C Y Ip, Tony C Y Pang, Cindy K Pon, et al.
ANZ Journal of Surgery|July 2, 2009
Outcomes of minimally invasive surgery for phaeochromocytomaGoswin Y Meyer-Rochow, Patsy S H Soon, Leigh W Delbridge, et al.
Surgery|November 11, 2018
Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimeticsWillemijn Y van der Plas, Anton F Engelsman, Marille Umakanthan, et al.
World Journal of Surgery|October 24, 2013
Patterns of structural recurrence in papillary thyroid cancerSchelto Kruijff, Japke F Petersen, Paul Chen, et al.
Surgery|September 24, 2019
Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillanceJia F Lin, Pascal K C Jonker, Michelle Cunich, et al.
Surgery|December 8, 2010
BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with papillary thyroid cancerChristine J O'Neill, Martyn Bullock, Angela Chou, et al.
Surgery|January 3, 2014
Decreasing the dose of radioiodine for remnant ablation does not increase structural recurrence rates in papillary thyroid carcinomaSchelto Kruijff, Ahmed M Aniss, Paul Chen, et al.
Cancers|August 8, 2020
Molecular Markers Guiding Thyroid Cancer ManagementCarolina Nylén, Robert Mechera, Isabella Maréchal-Ross, et al.
Endocrine Oncology (Bristol, England)|July 12, 2023
Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines updateBenjamin J Worrall, Alexander Papachristos, Ahmad Aniss, et al.
Pageof 10